| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 41 |
| 1 | HUMAN IMMUNOGLOBULIN G | 24 |
| 2 | TADALAFIL | 15 |
| 3 | ACETAMINOPHEN | 14 |
| 4 | SILDENAFIL CITRATE | 13 |
| 5 | ERGOCALCIFEROL | 11 |
| 6 | GABAPENTIN | 11 |
| 7 | SILDENAFIL | 11 |
| 8 | ACETAMINOPHEN 500MG | 10 |
| 9 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SARECYCLINE HYDROCHLORIDE | 1 | 0.0050 |
| 1 | INSULIN LISPRO-AABC | 4 | 0.0019 |
| 2 | TALIGLUCERASE ALFA | 1 | 0.0017 |
| 3 | BUTALBITAL AND ACETAMINOPHEN | 1 | 0.0016 |
| 4 | KETAMINE HYDROCHLORIDE | 7 | 0.0014 |
| 5 | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | 1 | 0.0013 |
| 6 | HUMAN IMMUNOGLOBULIN G | 24 | 0.0011 |
| 7 | OMEPRAZOLE, SODIUM BICARBONATE | 1 | 0.0010 |
| 8 | IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE | 3 | 0.0007 |
| 9 | PRAZOSIN HYDROCHLORIDE | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 41 |
| 1 | Human Immunoglobulin G [EPC] | 26 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 21 |
| 3 | Endothelin Receptor Antagonist [EPC] | 19 |
| 4 | Phosphodiesterase 5 Inhibitor [EPC] | 19 |
| 5 | Antiarrhythmic [EPC] | 14 |
| 6 | Amide Local Anesthetic [EPC] | 13 |
| 7 | Osmotic Laxative [EPC] | 11 |
| 8 | Provitamin D2 Compound [EPC] | 11 |
| 9 | Catecholamine [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin G [EPC] | 26 | 0.0012 |
| 1 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 2 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Provitamin D2 Compound [EPC] | 11 | 0.0004 |
| 4 | Prostacycline Vasodilator [EPC] | 41 | 0.0003 |
| 5 | Amide Local Anesthetic [EPC] | 13 | 0.0001 |
| 6 | RNA Synthetase Inhibitor Antibacterial [EPC] | 2 | 0.0001 |
| 7 | Antiarrhythmic [EPC] | 14 | 0.0001 |
| 8 | Phosphodiesterase 5 Inhibitor [EPC] | 19 | 0.0001 |
| 9 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |